Pre-clinical strategies and emerging technologies driving advances in the alpha-gal syndrome
Alpha-gal syndrome (AGS) is a unique allergic condition triggered by IgE antibody production against the mammalian oligosaccharide galactose-α-1,3-galactose (α-gal). The syndrome, acquired by bites from multiple tick species, leads to delayed allergic reactions after consuming mammalian-derived prod...
Saved in:
| Main Authors: | Loren D. Erickson, Jeffrey M. Wilson, Kayla Cramton, Claudia M. Rival |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Allergology International |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893025000280 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IgG to Galactose-Alpha-1,3-Galactose: Impact of Alpha-Gal IgE Sensitization, Blood Type, and Tick Bites
by: Samuel M. Ailsworth, et al.
Published: (2025-05-01) -
Opinion: Ecologists and entomologists wanted! An open invitation to alpha-gal syndrome research
by: Kate M. Barnett, et al.
Published: (2025-09-01) -
Alpha-gal allergy in a South Asian country
by: Dhanushka Dasanayake, et al.
Published: (2025-05-01) -
Alpha-gal syndrome and the gastrointestinal reaction: a narrative review
by: Susan B. H. Propst, et al.
Published: (2025-01-01) -
Alpha-Gal Syndrome: Often Hidden, Under-Recognized, and in Need of Attention—A Rapid Review
by: Thompson CC, et al.
Published: (2025-06-01)